MedCap AB
Overview
MedCap AB is a Swedish private equity firm specializing in investments within the life science sector. The firm focuses on acquiring and developing small and medium-sized, well-managed companies in the medical equipment, biotechnology, pharmaceuticals, and healthcare industries. MedCap aims to provide capital, expertise, experience, and networks to foster growth and international expansion for its portfolio companies. The firm's ownership approach is long-term, active, and professional, with a strong appreciation for the traditions of each business. The firm's investment strategy encompasses various stages, including early-stage, growth, late-stage, and buyout investments. MedCap's geographical focus spans the Nordic region and Northern Europe, with a particular emphasis on Sweden, Norway, Denmark, Finland, and Iceland. The firm also considers investments in other European countries such as the United Kingdom, Germany, France, the Netherlands, Belgium, Luxembourg, Switzerland, Austria, Poland, the Czech Republic, Slovakia, Hungary, Estonia, Latvia, and Lithuania. MedCap's portfolio includes companies operating in diverse sectors such as medical devices, biotechnology, pharmaceuticals, healthcare, assistive technology, medical equipment manufacturing, life sciences, MedTech, specialty pharma, healthcare services, medical supplies, healthcare technology, medical equipment, medical research, and medical manufacturing. The firm typically invests between SEK 50 million and SEK 200 million (approximately USD 6.6 million to USD 26.5 million) in companies with enterprise values ranging from SEK 50 million to SEK 200 million (approximately USD 6.6 million to USD 26.5 million). MedCap seeks to acquire stakes between 20% and 50% in its portfolio companies, utilizing its capital and loans to make balance sheet investments. MedCap's investment philosophy is centered on active ownership and management, aiming to create value by leveraging its expertise and networks to support the growth and development of its portfolio companies. The firm has a track record of successfully developing leading niche companies within the life science industry, contributing to the advancement of healthcare and medical technologies in the Nordic region and beyond.
Investment Focus
- Companies in the life science sector, including medical devices, biotechnology, pharmaceuticals, and healthcare industries
- Small and medium-sized, well-managed companies with growth potential
- Companies based in the Nordic region and Northern Europe, with a focus on Sweden, Norway, Denmark, Finland, and Iceland
- Companies with enterprise values ranging from SEK 50 million to SEK 200 million (approximately USD 6.6 million to USD 26.5 million)
- Companies seeking active ownership and management to support growth and development
Portfolio Companies
Reach MedCap AB directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about MedCap AB
What sectors does MedCap AB invest in?
MedCap AB invests in Healthcare, Life Sciences, Healthcare Services, Pharmaceuticals, Medical Devices and Medtech, and is based in Stockholm, Stockholm County, Sweden. MedCap AB is listed as a private equity in the ConnectSafely investor database.
What stage does MedCap AB invest at?
MedCap AB backs companies at Early Stage, Growth, Late Stage and Buyout, writing cheques of 26.6M - 133.2M.
Which regions does MedCap AB invest in?
MedCap AB invests across United Kingdom, Germany, France, Denmark, Switzerland and Luxembourg.
Who are the partners at MedCap AB?
Team members listed for MedCap AB include Kristina Ekblad (Chief Financial Officer) and Tove Christiansson (Head of Business Area Assistive Tech, Medcap).
What companies has MedCap AB invested in?
MedCap AB's portfolio includes Abilia, Cardiolex, Inpac, Multi-Ply, Unimedic, Trident, Huka and Erimed.
How do I contact MedCap AB?
MedCap AB's contact details — including LinkedIn — are listed in the ConnectSafely investor database, along with its website and the LinkedIn profiles of its partners.
Last updated · Source: ConnectSafely investor database
